Linike Medical Group Ltd(LNMG)
USD --+0.00%
Reward44Moderate
Risk56Medium-High
📊75%Data
LNMG
+0.0 · +0.00%
USD · PINK
Linike Medical Group Ltd | Healthcare
Earnings Deterioration
Market Cap:17.16M
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
56
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on LNMG to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Linike Medical Group Ltd?

engages in the renewable energy business.

LNMG · Verdict

Moderate reward · elevated risk

LNMG's standout is volatility; cash flow and profitability weigh on the picture.

Based on 88% data coverage

LNMG · Verdict

What’s working & what to watch

Strengths 1

  • Volatility75/100

    Above average

Watchouts 3

  • Cash flow8/100

    -8% free-cash-flow margin

  • Profitability32/100

    -2% net margin · 0% ROE

  • Growth41/100

    Earnings +101.7% CAGR

Model-based scoring. For information only — not financial advice.

What is Linike Medical Group Ltd?

engages in the renewable energy business. The company is involved in the creation of a solar farm in India. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 17.16M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap17.16M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0619
52 Week Low0.0028
Last AnnualOctober
IPO DateN/A
IncorporatedUSA
Shares Outstanding669M
No. of EmployeesN/A
IndustryMedical Devices
ExchangePINK
Beta-6.745
CurrencyUSD